Understanding the Benefits of SGLT2 Inhibition: Direct Effect on Epicardial Adipose Tissue

JACC Basic Transl Sci. 2023 Sep 25;8(9):1098-1099. doi: 10.1016/j.jacbts.2023.07.001. eCollection 2023 Sep.

Author

Affiliation

¹ Research and Early Clinical Development, Cardiovascular, Renal, and Metabolism, AstraZeneca BioPharmaceuticals R&D, Gaithersburg, Maryland, USA.

No abstract available

Keywords: epicardial adipose tissue; interleukin-6; paracrine effect; preadipocyte; sodium-glucose cotransporter 2 inhibitor.

Publication types

Editorial